117 related articles for article (PubMed ID: 37828768)
21. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
[TBL] [Abstract][Full Text] [Related]
22. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.
Tan X; Song X; Fan B; Li M; Zhang A; Pei L
Anticancer Drugs; 2022 Oct; 33(9):871-882. PubMed ID: 36136987
[TBL] [Abstract][Full Text] [Related]
23. The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.
Erdogan S; Serttas R; Turkekul K; Dibirdik I
Mol Biol Rep; 2022 Jun; 49(6):4873-4884. PubMed ID: 35705771
[TBL] [Abstract][Full Text] [Related]
24. Berbamine Inhibits the Biological Activities of Prostate Cancer Cells by Modulating the ROS/NF-κB Axis.
Zhao W; Jiang Y; Jia X; Wang X; Guo Y
Anticancer Agents Med Chem; 2023; 23(14):1626-1633. PubMed ID: 37638593
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
26. Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.
Li Q; Hu J; Shi Y; Xiao M; Bi T; Wang C; Yan L; Li X
Cell Cycle; 2021 Dec; 20(23):2531-2546. PubMed ID: 34724861
[TBL] [Abstract][Full Text] [Related]
27. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
28. Targeting Apoptotic Activity Against Prostate Cancer Stem Cells.
Jaworska D; Szliszka E
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758908
[TBL] [Abstract][Full Text] [Related]
29. Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer.
Sun SQ; Zhao YX; Li SY; Qiang JW; Ji YZ
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32784629
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of miR-124 inhibits invasion and proliferation of prostate cancer cells through mediating JAK-STAT3 signaling pathway.
Wu Z; Huang W; Chen B; Bai PD; Wang XG; Xing JC
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2338-2345. PubMed ID: 28617558
[TBL] [Abstract][Full Text] [Related]
31. The inhibition of circular RNA circNOLC1 by propofol/STAT3 attenuates breast cancer stem cells function via miR-365a-3p/STAT3 signaling.
Liu YP; Heng JY; Zhao XY; Li EY
J Transl Med; 2021 Nov; 19(1):467. PubMed ID: 34789263
[TBL] [Abstract][Full Text] [Related]
32. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells.
Mukhtar E; Adhami VM; Siddiqui IA; Verma AK; Mukhtar H
Mol Cancer Ther; 2016 Dec; 15(12):2863-2874. PubMed ID: 27765854
[TBL] [Abstract][Full Text] [Related]
33. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
34. miR-26b-5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC.
Khosla R; Hemati H; Rastogi A; Ramakrishna G; Sarin SK; Trehanpati N
Liver Int; 2019 Sep; 39(9):1692-1703. PubMed ID: 31276277
[TBL] [Abstract][Full Text] [Related]
35. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
36. Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.
Jiang L; Zhang Y; Guo L; Liu C; Wang P; Ren W
BMC Cancer; 2021 Dec; 21(1):1290. PubMed ID: 34856955
[TBL] [Abstract][Full Text] [Related]
37. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
[TBL] [Abstract][Full Text] [Related]
38. Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop.
Xu T; Xie M; Jing X; Jiang H; Wu X; Wang X; Shu Y
J Transl Med; 2023 Feb; 21(1):77. PubMed ID: 36737782
[TBL] [Abstract][Full Text] [Related]
39. Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer.
Kato T; Mizutani K; Kameyama K; Kawakami K; Fujita Y; Nakane K; Kanimoto Y; Ehara H; Ito H; Seishima M; Deguchi T; Ito M
Urol Oncol; 2015 Sep; 33(9):385.e15-20. PubMed ID: 26027763
[TBL] [Abstract][Full Text] [Related]
40. Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761/HDAC1 Axis and Activation of STAT3-Mediated Inflammation.
Zhang L; Yu Z; Qu Q; Li X; Lu X; Zhang H
Int J Nanomedicine; 2022; 17():1155-1170. PubMed ID: 35321026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
